VN
EN
Close Menu
Home page
About Us
About Imexpharm
Our Culture
Our Journey
People
Potential
News
Imexpharm News
Events
Specialized
Community Activities
Products
Product Groups
Products A-Z
Investors
IMP stock information
Financial information
Annual Report & Sustainability Report
AGM
Corporate Governance
Information Disclosure
Analyst Report
News - Events
Community
Careers
Media
Contact
Home
Investors
Information Disclosure
IMP stock
information
Financial
information
Annual Report &
Sustainability Report
AGM
Corporate
Governance
Information
Disclosure
Analyst
Report
News &
Events
Close Filter
Find report
Search
Information Disclosure
IMP - Resolution No. 08 of the BOD on the dismissal of the Deputy General Director cum CFO
07/21/2025
Download
IMP - Disclosure of Q2.2025 Financial Statements and Explanation for PAT growth
07/18/2025
Download
IMP - Disclosing on signing the audit contract for the fiscal year 2025
07/04/2025
Download
IMP - BOD Resolution No. 07 on the approval of the selection of an Independent Audit Firm for FY2025
06/05/2025
Download
IMP - Disclosing the maximum foreign ownership limit
06/04/2025
Download
IMP - HOSE Notice No. 972 on the Record Date for Cash Dividend Payment
05/26/2025
Download
IMP - Confirmation of public disclosure on Imexpharm share transfer by major shareholders
05/23/2025
Download
IMP - VSDC Notice No. 1077 on the Record Date for Exercising Rights of Securities Holders
05/23/2025
Download
IMP - Confirmation Letter on changing of enterprise registration information dated May 21, 2025
05/22/2025
Download
IMP - BOD Resolution No.06 on approval of the record date for finalizing the list of shareholders entitled for 2024 cash dividend payment
05/22/2025
Download
«
‹
1
2
3
4
5
6
7
8
9
10
›
»